Re-imagining e-SBIRT to reduce stigma and strengthen FASD prevention
Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11442912 · Data updated 2026-11-12
A new approach uses digital support to help pregnant people reduce alcohol use and prevent FASD, aiming to fit into routine prenatal care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project start | August 15, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $509,560 |
| NIH project number | 1R61AA033479-01 |
| Project ID | NIH-11442912 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant individuals who consume alcohol or are at risk for alcohol use disorder and who are receiving care in prenatal health settings.
✕Less likely to help
Pregnant people who do not consume alcohol or are not within the target risk range may not benefit.
What this research studies
This grant focuses on improving digital screening and brief intervention for alcohol use during pregnancy by integrating e-SBIRT into standard prenatal checkups and adding supportive digital tools. The study intends to test scalable delivery within the health care visit framework to reach pregnant individuals who may not seek traditional treatment. It also explores enhancements such as messages and booster sessions to boost impact while addressing stigma. The research is conducted across collaborating institutions to evaluate feasibility, acceptability, and preliminary effectiveness in real-world prenatal settings.
Why it matters
Potential benefit: If successful, this approach could reduce alcohol use during pregnancy and lower the risk of FASD for unborn children.
How similar studies have gone: Prior digital SBIRT approaches showed promise, with enhanced outcomes when combined with digital dose boosters, but real-world scalability remains a question.
Where this research is happening
-
Henry Ford Health + Michigan State University Health Sciences
East Lansing, United States Active
Researchers
- Principal investigator: Ondersma, Steven J — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Ondersma, Steven J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.